ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RMCO vs TMO // GROSS PROFIT MARGIN

Royalty Management Holding Corporation (Class A) (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: RMCO 2 — TMO 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RMCO VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RMCO TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 16.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -1.70% 9.30% -11.00 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -0.03% 2.40% -2.43 TMO /fcf-yield <GO>
Operating Margin -5.90% 17.40% -23.30 TMO /operating-margins <GO>
Net Profit Margin -14.70% 15.10% -29.80 TMO /net-margins <GO>
Revenue Growth (YoY) 180.00% 3.90% +176.10 RMCO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 7.52 4.50 +3.02 RMCO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.7 62.9 -20.17 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $35.7M $262.22B -$262.18B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RMCO REV TMO REV RMCO GROSS % TMO GROSS % RMCO FCF TMO FCF
FY 2025 $4.9M $44.56B 16.3% — -$9.0K $6.29B
FY 2024 $807.1K $42.88B 97.2% — $646.3K $7.27B
FY 2023 $488.5K $42.86B — — -$236.9K $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RMCO // BETA —
TMO // BETA 0.94